ZenoWell, maker of wearable auricular vagus nerve stimulation (taVNS) devices, is expanding its Luna and Vita platforms into 100 specialty clinics and therapy centers across the U.S., Europe, Hong Kong, and Singapore.
These aren’t hospital systems or integrated health networks. ZenoWell is entering the physiotherapy and alternative wellness space — practitioners operating in boutique clinics, rehab studios, functional health centers, and independent therapy practices where clients come seeking support outside the conventional medical model.
The partner network spans a wide range of adult health disciplines: neurology-adjacent care, mental health support, occupational therapy (psychiatric and orthopedic), clinical neurofeedback, counseling, psychosocial rehabilitation, physical therapy, primary care, preventive health screening, functional medicine, naturopathy, and wellness recovery programs. What connects them is a shared challenge — clients who need consistent, ongoing support that a weekly or biweekly appointment simply can’t deliver on its own.
That’s the gap ZenoWell is built to close. Partner centers introduce the Luna and Vita vagus nerve wearables — which target the auricular branch of the vagus nerve — through hands-on orientation sessions, then extend care into structured at-home programs. Clients leave with a device and a clear protocol. Practitioners stay connected. Nervous system support doesn’t stop at the clinic door.
The conditions in focus are ones that practitioners at wellness and integrative health centers know well: stress dysregulation, poor sleep, anxiety, mood instability, trauma symptoms, attention and cognitive concerns, perimenopause, metabolic and gut health, chronic pain, IBS, POTS, and broader autonomic dysfunction. Many of these clients have already cycled through conventional care without resolution — they’re at wellness centers precisely because they’re looking for something different.
ZenoWell isn’t positioning taVNS as a replacement for any therapeutic modality. It’s a non-pharmacological nervous system support layer that sits alongside existing practice offerings. The device also pairs naturally with occupational and physical rehab, corporate wellness programming, continuing education, and recovery modalities like infrared sauna, cold therapy, and photobiomodulation — making it a practical add-on for centers already running multi-modal programs.
Functional and integrative medicine centers have shown particular interest. Several partners focus on gut health, metabolic regulation, allergy care, and pain management — areas where autonomic nervous system support is drawing growing attention from practitioners looking to go beyond symptom management.
Alongside the expansion, ZenoWell is launching a research grant program for partner practitioners who want to generate real-world evidence from their own client populations. Priority areas include chronic insomnia, persistent somatic pain, PTSD, anxiety and stress regulation, depressive symptom management, trauma recovery, and cognitive performance. The program gives practitioners a framework to collect usage data, track client-reported outcomes, and develop best practices tailored to their specific settings. De-identified, aggregated findings will feed back into ZenoWell’s protocol refinement and application guidance over time.
“Many people managing chronic stress, sleep problems, pain, and mood dysregulation need support that extends well beyond what a single session can offer,” said Dr. Jane, Chief Scientist at ZenoWell. “Partnering with wellness and integrative therapy centers lets us meet clients where they already are — and give practitioners a tool that keeps working between visits.”
The broader positioning sets ZenoWell apart from the consumer wearable category. Where most wearables stop at tracking, ZenoWell pairs hardware with practitioner-guided protocols — centers handle client assessment and ongoing support, clients use the device to sustain that care at home. The company distributes through both direct-to-consumer and wellness professional channels.
Incubated at Heidelberg University Medical School, ZenoWell is the world’s leading vagus nerve wearable company, pioneering non-invasive auricular taVNS technology for autonomic nervous system regulation and targeted neurological improvement. ZenoWell Luna and Vita product lines — each tailored to distinct user needs — support sleep, stress recovery, pain management, metabolic health, focus, and mood regulation, available through both wellness professional partnerships and direct-to-consumer channels.
press@zenowell.ai
ZenoWell
